Understanding your options can make the next step feel clearer.
Patients facing cancer or autoimmune conditions often want to understand what supportive and integrative options may be considered. Explore the therapies available at BioCare, learn how they may fit into an individualized program, and go deeper into the options you want to understand better.
You don’t have to sort through every option all at once.
Whether you are navigating cancer or an autoimmune condition, one of the biggest questions is often the simplest: What options are available to me? This page is meant to help you get oriented without feeling overwhelmed.
The therapies below introduce selected supportive and integrative options available at BioCare for patients with cancer, autoimmune conditions, and other complex medical needs. They are not presented as a fixed package, and not every therapy is appropriate for every diagnosis. Your physician considers your condition, medical history, current treatment, symptoms, and individual needs before discussing what may be appropriate.
Explore by treatment
Choose the therapies you want to understand better. Each option includes a plain-language overview plus additional technical details for patients and families who want to look more closely.
A simple way to use this page: start with the treatments that sound most relevant to your situation, read the short overview, and then open the expanded technical section only if you want deeper detail.
Personalized Cancer & Autoimmune Programs
BioCare’s integrative model is built around biological individuality: no two patients are approached in exactly the same way. Patients with cancer and autoimmune conditions may arrive with very different diagnoses, symptoms, treatment histories, and priorities. The program is organized around the patient’s diagnosis or condition, medical history, nutritional status, current treatment, and overall health rather than around a predetermined package of therapies.
The medical team may consider nutritional support, symptom-focused supportive care, immune and metabolic support, and selected integrative modalities. Cancer and autoimmune programs are not treated as interchangeable: which elements are considered, and in what sequence, depends on the diagnosis, current medical treatment, overall condition, and individual physician evaluation.
How BioCare builds the program The medical team considers the patient’s diagnosis or autoimmune condition, current treatment, symptoms, nutritional status, overall health, and medical needs when developing and sequencing the program. Some therapies may be considered only when they are clinically appropriate for that individual patient.
Read more technical information
Individualized and successive planning
BioCare’s model emphasizes a phased, individualized approach rather than a one-size-fits-all protocol. For both cancer and autoimmune care, the patient’s overall condition, nutrition, symptoms, current treatment, and supportive needs are considered alongside any specific integrative intervention.
Components that may be considered
Assessment of the patient as a whole rather than focusing only on the diagnosis or condition
Review of current cancer treatment, autoimmune medications, or specialist-directed care
Nutrition, metabolic status, symptoms, and general supportive needs
Consideration of immune function and the patient’s overall clinical condition
Selection and sequencing of integrative modalities according to the individual case
Why sequencing matters
Some therapies may be considered only after certain clinical goals have been reached, while others may not be appropriate for a particular diagnosis or medication regimen. Physician evaluation and ongoing reassessment are therefore central to the program.
Whole-Body Hyperthermia
Experience matters when treatment requires careful medical control.
When considering Whole-Body Hyperthermia, the important question is not simply whether a hospital offers it. It is how carefully the patient is evaluated, how the treatment is planned and medically managed, and what level of clinical supervision surrounds the entire process.
At BioCare Hospital, decades of experience in integrative medicine have shaped the way we approach Whole-Body Hyperthermia: not simply as a procedure, but as part of an individualized medical program that begins with careful patient selection and continues with close monitoring before, during, and after treatment.
For us, experience means understanding that hyperthermia is not simply about raising body temperature. It means evaluating whether the patient may be an appropriate candidate, considering how their overall condition may affect treatment, and determining how hyperthermia should fit within the rest of their medical care.
Before treatment, our medical team considers the patient’s diagnosis and stage of disease, overall and nutritional condition, current treatment, and particularly cardiovascular and pulmonary status. Clinical findings, laboratory information, and imaging may also be reviewed as part of the planning process.
Technology is only one part of hyperthermia. Knowing when to use it, how to manage it, and how to care for the patient throughout the process is just as important.
What BioCare evaluates before treatment
Whole-Body Hyperthermia is not automatically appropriate for every patient. Patient selection is based on the overall clinical picture, including diagnosis, disease stage, nutritional condition, heart and lung function, and other relevant medical information.
The goal is to determine not only whether hyperthermia may be considered, but how it can be incorporated responsibly into the patient’s broader care plan.
Read more technical information
The physiological concept
Hyperthermia refers to the controlled elevation of body temperature. The biological rationale is related to the way thermal stress affects cellular processes and the body’s response to increased temperature. Apoptosis, or programmed cell death, is one of the biological mechanisms relevant to hyperthermia research.
Why careful patient selection matters
Candidates are evaluated not only according to the primary diagnosis, but also according to their overall condition, nutritional status, heart and lung function, and other relevant clinical findings. This information helps the medical team determine whether the procedure should be considered and how it may fit within the broader treatment plan.
Medical supervision and monitoring
Whole-Body Hyperthermia is performed under controlled medical conditions. Monitoring during treatment and observation afterward are important parts of managing the physiological demands associated with intentionally increasing core body temperature.
Part of an integrative program
At BioCare, hyperthermia is considered within the context of the patient’s broader medical program. Nutritional status, metabolic condition, current treatment, and overall clinical situation are taken into account before and after the procedure.
Dendritic Cell Vaccine
Dendritic Cell Vaccine is an autologous immune-focused approach, meaning that cells and immune factors are obtained from the patient. Dendritic cells are specialized antigen-presenting cells that help the immune system recognize abnormal targets and communicate that information to T-cells.
At BioCare, blood-derived dendritic-cell elements are isolated and concentrated, then undergo a process of maturation and activation in a supportive laboratory environment. The prepared cellular product is then returned to the patient with the goal of improving immune recognition of tumor-associated antigens.
The exact preparation can vary by protocol, so the relevant questions are how the cells are obtained, processed, activated, and incorporated into the patient’s overall treatment plan.
How the process works Immune-cell elements are obtained from the patient’s own blood, isolated and concentrated, and then prepared through a maturation and activation process before the cellular product is administered back to the patient.
Read more technical information
Immune-recognition concept
Dendritic cells are white blood cells involved in recognizing abnormal or foreign material. Their antigen-presenting function helps communicate identifying information to T-cells, which can then participate in an immune response.
Autologous preparation
Blood is obtained from the patient
Dendritic-cell and related immune elements are isolated and concentrated
The cellular concentrate undergoes maturation and activation in a supportive nutritive environment
The prepared product is subsequently administered back to the patient
Role of dendritic cells
Dendritic cells can take up antigenic material and present it to immune cells in lymphoid tissue. This antigen-presenting function is the biological basis for using dendritic cells to help the immune system recognize tumor-associated targets.
Protocol considerations
Preparation methods, antigen sources, cell maturation techniques, dosing, and schedules can differ, so the exact protocol proposed for an individual patient should be clearly defined.
Autologous Stem Cell Therapy
Autologous means that the cells used in the procedure come from the patient rather than from a donor. At BioCare, this regenerative approach is described as involving the collection, concentration, culture, and re-insertion of the patient’s own cells.
The therapy is positioned within regenerative medicine and focuses on the potential role of autologous cells in tissue repair and biological restoration. Because “stem cell therapy” can refer to very different procedures, the cell source, processing method, intended use, and clinical objective should always be clearly identified.
There is no single universal stem-cell protocol for every diagnosis. Suitability depends on the patient’s medical condition, the type of cells being used, how they are processed, and the reason the therapy is being considered.
How the process works Autologous means the cells originate from the patient. The process may involve collection, concentration, culture or other processing, and re-administration as part of an individualized regenerative medicine protocol.
Read more technical information
Core process
The process is described as collection, concentration, culture, and re-insertion of cells obtained from the patient, within the broader field of regenerative medicine.
Why “autologous” matters
Using autologous material means the starting cells are derived from the same patient who will receive the final preparation. The clinical meaning of the procedure depends on the precise cell population, how it is handled, and the intended therapeutic purpose.
Questions that define the protocol
What is the source of the cells?
How are the cells collected and concentrated?
Does the protocol involve culture or other processing?
How are the cells returned to the patient?
What clinical objective is being proposed for this particular case?
Individual medical evaluation
The procedure is considered within an individualized program, so the patient’s diagnosis, current treatment, medical condition, and the characteristics of the cellular product all matter.
Ultraviolet Blood Irradiation (UBI)
Ultraviolet Blood Irradiation is an extracorporeal procedure in which a portion of the patient’s blood is removed, exposed to ultraviolet light outside the body, and then returned to the circulation.
How the procedure is performed A portion of blood is withdrawn, exposed to ultraviolet light under controlled conditions outside the body, and then reinfused. The amount of blood treated, exposure parameters, and treatment schedule can vary by protocol.
Read more technical information
Procedure sequence
The process involves blood withdrawal, controlled ultraviolet exposure outside the body, and reinfusion. This makes UBI an extracorporeal blood-treatment procedure rather than an external light treatment applied directly to the patient.
Protocol variables
Volume of blood processed
Ultraviolet exposure parameters
Anticoagulation and blood-handling procedures
Frequency and number of sessions
How it fits into the program
UBI is one of several integrative modalities that may be selected within a broader individualized care plan rather than a universal treatment for every patient.
IV Nutritional Therapy
IV Nutritional Therapy is part of BioCare’s broader nutritional approach. Depending on the patient’s condition, nutritional support may include intravenously or orally administered nutrients such as vitamins, minerals, amino acids, essential fatty acids, phytonutrients, enzymes, and other supportive components.
How nutritional support is individualized The formulation and route are selected according to the patient’s condition and nutritional needs. Oral support may be sufficient for some patients, while intravenous support may be considered when more direct nutritional delivery is clinically appropriate.
Read more technical information
Nutritional components
Support may include vitamins, minerals, amino acids, essential fatty acids, phytonutrients, enzymes, probiotics, and other nutritional components according to the patient’s needs.
Why the route can differ
Oral and intravenous approaches serve different purposes. The route depends on the patient’s condition, nutritional status, tolerance, and ability to maintain adequate intake.
Clinical considerations
Current nutritional status and oral intake
Kidney and liver function
Hydration and electrolyte status
Medication and treatment interactions
Specific purpose of each proposed ingredient
Nutrition & Supportive Care
Nutrition is considered part of the foundation of BioCare’s integrative program. The approach considers dietary intake, nutritional deficiencies, appetite, digestion, hydration, and the patient’s ability to maintain adequate nourishment during treatment.
Why nutrition is individualized There is no single diet appropriate for every patient. Nutritional planning is adapted to the individual, including appetite, weight changes, digestive tolerance, hydration, and the broader medical plan.
Read more technical information
Individualized nutrition
Nutritional planning follows the same principle of biological individuality used throughout the BioCare System.
Areas considered in supportive care
Ability to maintain adequate calorie and protein intake
Appetite and digestive tolerance
Hydration and nutritional deficiencies
Oral versus intravenous nutritional support when clinically appropriate
Coordination with the patient’s broader treatment plan
Role within the program
Nutritional restoration is considered one part of a broader integrative program intended to support the patient’s general condition before and during more intensive interventions.
Ozone Therapy
Ozone Therapy is included among BioCare’s oxidative therapies. Ozone is a molecule composed of three oxygen atoms (O3), and the exact protocol can vary according to route, concentration, dose, and treatment schedule.
How this therapy is categorized Ozone is considered one of BioCare’s oxidative modalities. The route of administration, concentration, dose, frequency, and clinical purpose should be defined for the individual patient.
Read more technical information
How ozone is classified
Ozone is chemically O3 and is used within the broader category of oxidative therapies.
Protocol variables
Route of administration
Ozone concentration and dose
Frequency and number of sessions
Clinical rationale for the individual patient
Individual evaluation
Ozone is one component that may be selected within an integrative program, making physician review of the patient’s medical condition and current treatment important before it is considered.
Hyperbaric Oxygen Therapy
Hyperbaric Oxygen Therapy involves placing the patient in a chamber where oxygen is delivered under increased atmospheric pressure, increasing the amount of oxygen carried in the blood and delivered to tissues.
How the procedure works The patient is treated inside a pressurized chamber while breathing oxygen. The pressure level, session duration, frequency, and clinical objective are determined according to the individual case.
Read more technical information
Physical principle
Increased atmospheric pressure allows more oxygen to be carried in the blood and delivered to tissues during the treatment session.
Clinical variables
Medical reason for considering hyperbaric oxygen
Pressure and duration of each session
Number and frequency of sessions
Screening for pulmonary, ear, sinus, neurologic, or medication-related considerations
Role in an integrative program
Hyperbaric oxygen is used as a supportive modality with a clinical purpose defined for the individual patient rather than as a universal treatment for every diagnosis.
Advanced Diagnostic Assessment
Diagnostic assessment is an important part of treatment planning and follow-up. Clinical information, laboratory findings, imaging, and other relevant records can help the medical team better understand the patient’s condition before and during an individualized program.
How diagnostic information supports planning Clinical findings, laboratory information, imaging, and relevant medical records are reviewed to clarify the current clinical picture, identify information needed before treatment planning, and help follow changes over time.
Read more technical information
Information used in assessment
Clinical staging, laboratory findings, tumor markers when applicable, and radiological studies such as CT and MRI may be used to evaluate disease status and follow changes over time.
Purpose of diagnostic review
Clarify the current clinical picture
Identify information needed before treatment planning
Establish objective findings that can be followed over time
Support decisions about sequencing or modifying the program
Current availability
Specific tests and diagnostic services should be confirmed with the medical team because the exact studies used depend on the individual case and current clinical resources.
Not every therapy is appropriate for every patient. Recommendations require physician evaluation. Supportive integrative programs are not a substitute for conventional cancer treatment or appropriate specialist-directed care for autoimmune disease. No treatment outcome is guaranteed.
Questions are a good place to start.
Start with a conversation, not a commitment.
A patient coordinator can help arrange a complimentary conversation with our medical team. You do not need to decide on treatment or travel to ask about your options.
